Lorcaserin and Behavioral Modification for Overweight and Obesity Management in Chinese Obese Patients

Summary

The purpose of this study is to assess the safety and weight loss effect of lorcaserin at the end of the first year of treatment (Week 48) in overweight and Chinese adult obese patients compared to placebo.

Timeline

Start

2019-09-17

Primary completion

2020-12-06

Completion

2020-12-12

Drugs

Indications